Jivi 2000 Unit

JIVI 2000 Unit is a recombinant antihemophilic factor used for hemophilia B treatment. This powder for solution is designed for intravenous administration and is manufactured by Bayer Inc.

JIVI 2000 Unit is primarily used for the treatment and prevention of bleeding episodes in patients with hemophilia B, a genetic disorder that affects blood clotting. This medication is formulated to replace the missing clotting factor IX, which helps control bleeding. It is often used in situations where rapid clotting is necessary, such as during surgery or after an injury. Patients may also use it as a preventive measure to reduce the frequency of bleeding episodes.

JIVI 2000 Unit works by replacing the missing clotting factor IX in the blood, which helps to form a stable blood clot. This can reduce the duration and severity of bleeding episodes. Some users may experience common side effects such as headache, nausea, or mild allergic reactions. These effects are generally mild and temporary, but any severe or persistent symptoms should be reported to a healthcare provider.

JIVI 2000 Unit should be handled with care and stored according to the manufacturer's instructions to maintain its effectiveness. It is important to follow proper administration techniques to ensure safe and effective use. Patients should be monitored for any signs of allergic reactions or other adverse effects. This medication should only be used under the supervision of a healthcare professional.

JIVI 2000 Unit may interact with other medications, particularly those that affect blood clotting. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain supplements may also affect the effectiveness of this medication. Always consult with a healthcare professional before starting any new medication.